WARSAW, Ind., March 19, 2018 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Coleman (Cole) N. Lannum has been appointed Senior Vice President of Investor Relations, reporting directly to the Company’s President and CEO, Bryan C. Hanson.
Mr. Lannum joins Zimmer Biomet with more than 15 years of Investor Relations (IR) experience in the healthcare industry. Most recently, he served as Senior Vice President of Investor Strategy and Investor Relations Officer for Mallinckrodt Pharmaceuticals, where he consulted with executive management and the Board of Directors regarding the Company’s acquisitions, strategic direction and shareholder value optimization.
Prior to joining Mallinckrodt in 2015, Mr. Lannum led IR at Covidien and Tyco Healthcare for nine years. As Vice President and Investor Relations Officer, he designed Covidien’s IR program, oversaw the largest-ever healthcare Initial Public Offering and led the IR effort through the company’s merger with Medtronic in 2015.
Mr. Lannum’s leadership at Covidien and Mallinckrodt has been recognized with numerous best-in-class honors, including an unprecedented five consecutive awards by IR Magazine for both Best US Investor Relations Officer – Large Cap and Grand Prix – Best Overall Investor Relations from 2011 through 2015.
About Zimmer Biomet
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.
We have operations in more than 25 countries around the world and sell products in more than 100 countries. For more information, visit www.zimmerbiomet.com, or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.
SOURCE Zimmer Biomet Holdings, Inc.